Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Society of Anesthesiologists. Practice guidelines for obstetrical anesthesia: a report by the American Society of Anesthesiologists Task Force on Obstetrical Anesthesia. Anesthesiology 1999 Feb;90(2):600-11.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

  1. Perianesthetic Evaluation
    • Conduct a focused history and physical examination before providing anesthesia care
      • Maternal health and anesthetic history
      • Relevant obstetric history
      • Airway and heart and lung examination
      • Baseline blood pressure measurement
      • Back examination when neuraxial anesthesia is planned or placed
    • A communication system should be in place to encourage early and ongoing contact between obstetric providers, anesthesiologists, and other members of the multidisciplinary team
    • Order or require a platelet count based on a patient's history, physical examination, and clinical signs; a routine intrapartum platelet count is not necessary in the healthy parturient
    • Order or require an intrapartum blood type and screen or cross-match based on maternal history, anticipated hemorrhagic complications (e.g., placenta accreta in a patient with placenta previa and previous uterine surgery), and local institutional policies; a routine blood cross-match is not necessary for healthy and uncomplicated parturients
    • The fetal heart rate should be monitored by a qualified individual before and after administration of neuraxial analgesia for labor; continuous electronic recording of the fetal heart rate may not be necessary in every clinical setting and may not be possible during initiation of neuraxial anesthesia
  1. Aspiration Prophylaxis
    • Oral intake of modest amounts of clear liquids may be allowed for uncomplicated laboring patients
    • The uncomplicated patient undergoing elective cesarean delivery may have modest amounts of clear liquids up to 2 hours before induction of anesthesia
    • The volume of liquid ingested is less important than the presence of particulate matter in the liquid ingested
    • Patients with additional risk factors for aspiration (e.g., morbid obesity, diabetes, difficult airway) or patients at increased risk for operative delivery (e.g., nonreassuring fetal heart rate pattern) may have further restrictions of oral intake, determined on a case-by-case basis
    • Solid foods should be avoided in laboring patients
    • Patients undergoing elective surgery (e.g., scheduled cesarean delivery or postpartum tubal ligation) should undergo a fasting period for solids of 6–8 hours depending on the type of food ingested (e.g., fat content)
    • Before surgical procedures (i.e., cesarean delivery, postpartum tubal ligation), practitioners should consider timely administration of nonparticulate antacids, histamine (H2) receptor antagonists, and/or metoclopramide for aspiration prophylaxis
  1. Anesthetic Care for Labor and Delivery

    Neuraxial Techniques: Availability of Resources

    • When neuraxial techniques that include local anesthetics are chosen, appropriate resources for the treatment of complications (e.g., hypotension, systemic toxicity, high spinal anesthesia) should be available
    • If an opioid is added, treatments for related complications (e.g., pruritus, nausea, respiratory depression) should be available
    • An intravenous infusion should be established before the initiation of neuraxial analgesia or anesthesia and maintained throughout the duration of the neuraxial analgesic or anesthetic
    • Administration of a fixed volume of intravenous fluid is not required before neuraxial analgesia is initiated

    Timing of Neuraxial Analgesia and Outcome of Labor

    • Neuraxial analgesia should not be withheld on the basis of achieving an arbitrary cervical dilation, and should be offered on an individualized basis when this service is available
    • Patients may be reassured that the use of neuraxial analgesia does not increase the incidence of cesarean delivery

    Neuraxial Analgesia and Trial of Labor after Previous Cesarean Delivery

    • Neuraxial techniques should be offered to patients attempting vaginal birth after previous cesarean delivery
    • For these patients, it is also appropriate to consider early placement of a neuraxial catheter that can be used later for labor analgesia or for anesthesia in the event of operative delivery

    Early Insertion of Spinal or Epidural Catheter for Complicated Parturients

    • Early insertion of a spinal or epidural catheter for obstetric (e.g., twin gestation or preeclampsia) or anesthetic indications (e.g., anticipated difficult airway or obesity) should be considered to reduce the need for general anesthesia if an emergent procedure becomes necessary
      • In these cases, the insertion of a spinal or epidural catheter may precede the onset of labor or a patient's request for labor analgesia

    Continuous Infusion Epidural (CIE) Analgesia

    • The selected analgesic/anesthetic technique should reflect patient needs and preferences, practitioner preferences or skills, and available resources
    • Continuous infusion epidural may be used for effective analgesia for labor and delivery
    • When a continuous epidural infusion of local anesthetic is selected, an opioid may be added to reduce the concentration of local anesthetic, improve the quality of analgesia, and minimize motor block
    • Adequate analgesia for uncomplicated labor and delivery should be administered with the secondary goal of producing as little motor block as possible by using dilute concentrations of local anesthetics with opioids
    • The lowest concentration of local anesthetic infusion that provides adequate maternal analgesia and satisfaction should be administered

    Single-injection Spinal Opioids with or without Local Anesthetics

    • Single-injection spinal opioids with or without local anesthetics may be used to provide effective, although time-limited, analgesia for labor when spontaneous vaginal delivery is anticipated
    • If labor is expected to last longer than the analgesic effects of the spinal drugs chosen or if there is a good possibility of operative delivery, a catheter technique instead of a single injection technique should be considered
    • A local anesthetic may be added to a spinal opioid to increase duration and improve quality of analgesia

    Pencil-point Spinal Needles

    • Pencil-point spinal needles should be used instead of cutting-bevel spinal needles to minimize the risk of post-dural puncture headache

    Combined Spinal–Epidural (CSE) Anesthetics

    • CSE techniques may be used to provide effective and rapid analgesia for labor

    Patient-controlled Epidural Analgesia (PCEA)

    • PCEA may be used to provide an effective and flexible approach for the maintenance of labor analgesia
    • PCEA may be preferable to continuous infusion epidural for providing fewer anesthetic interventions, reduced dosages of local anesthetics, and less motor blockade than fixed-rate continuous epidural infusions
    • PCEA may be used with or without a background infusion
  1. Removal of Retained Placenta
    • In general, there is no preferred anesthetic technique for removal of retained placenta
      • If an epidural catheter is in place and the patient is hemodynamically stable, epidural anesthesia is preferable
    • Hemodynamic status should be assessed before administering neuraxial anesthesia
    • Aspiration prophylaxis should be considered
    • Sedation/analgesia should be titrated carefully due to the potential risks of respiratory depression and pulmonary aspiration during the immediate postpartum period
    • In cases involving major maternal hemorrhage, general anesthesia with an endotracheal tube may be preferable to neuraxial anesthesia
    • Nitroglycerin may be used as an alternative to terbutaline sulfate or general endotracheal anesthesia with halogenated agents for uterine relaxation during removal of retained placental tissue
      • Initiating treatment with incremental doses of intravenous or sublingual (i.e., metered dose spray) nitroglycerin may relax the uterus sufficiently while minimizing potential complications (e.g., hypotension)
  1. Anesthetic Choices for Cesarean Delivery
    • Equipment, facilities, and support personnel available in the labor and delivery operating suite should be comparable to those available in the main operating suite
      • Resources for the treatment of potential complications (e.g., failed intubation, inadequate analgesia, hypotension, respiratory depression, pruritus, vomiting) should be available in the labor and delivery operating suite
      • Appropriate equipment and personnel should be available to care for obstetric patients recovering from major neuraxial or general anesthesia
    • The decision to use a particular anesthetic technique should be individualized based on anesthetic, obstetric, or fetal risk factors (e.g., elective vs. emergency), the preferences of the patient, and the judgment of the anesthesiologist
      • Neuraxial techniques are preferred to general anesthesia for most cesarean deliveries
    • An indwelling epidural catheter may provide equivalent onset of anesthesia compared with initiation of spinal anesthesia for urgent cesarean delivery
    • If spinal anesthesia is chosen, pencil-point spinal needles should be used instead of cutting-bevel spinal needles
    • General anesthesia may be the most appropriate choice in some circumstances (e.g., profound fetal bradycardia, ruptured uterus, severe hemorrhage, severe placental abruption)
    • Uterine displacement (usually left displacement) should be maintained until delivery regardless of the anesthetic technique used
    • Intravenous fluid preloading may be used to reduce the frequency of maternal hypotension after spinal anesthesia for cesarean delivery
    • Initiation of spinal anesthesia should not be delayed to administer a fixed volume of intravenous fluid
    • Intravenous ephedrine and phenylephrine are both acceptable drugs for treating hypotension during neuraxial anesthesia
      • In the absence of maternal bradycardia, phenylephrine may be preferable because of improved fetal acid-base status in uncomplicated pregnancies
    • For postoperative analgesia after neuraxial anesthesia for cesarean delivery, neuraxial opioids are preferred over intermittent injections of parenteral opioids
  1. Postpartum Tubal Ligation
    • For postpartum tubal ligation, the patient should have no oral intake of solid foods within 6–8 hours of the surgery, depending on the type of food ingested (e.g., fat content)
    • Aspiration prophylaxis should be considered
    • Both the timing of the procedure and the decision to use a particular anesthetic technique (i.e., neuraxial vs. general) should be individualized, based on anesthetic risk factors, obstetric risk factors (e.g., blood loss), and patient preferences
    • Neuraxial techniques are preferred to general anesthesia for most postpartum tubal ligations
      • Be aware that gastric emptying will be delayed in patients who have received opioids during labor and that an epidural catheter placed for labor may be more likely to fail with longer postdelivery time intervals
    • If a postpartum tubal ligation is to be performed before the patient is discharged from the hospital, the procedure should not be attempted at a time when it might compromise other aspects of patient care on the labor and delivery unit
  1. Management of Obstetric and Anesthetic Emergencies
    • Institutions providing obstetric care should have resources available to manage hemorrhagic emergencies
      • In an emergency, the use of type-specific or O negative blood is acceptable
      • In cases of intractable hemorrhage when banked blood is not available or the patient refuses banked blood, intraoperative cell-salvage should be considered if available
      • The decision to perform invasive hemodynamic monitoring should be individualized and based on clinical indications that include the patient's medical history and cardiovascular risk factors
    • Labor and delivery units should have personnel and equipment readily available to manage airway emergencies, to include a pulse oximeter and qualitative carbon dioxide detector, consistent with the American Society of Anesthesiologists (ASA) Practice Guidelines for Management of the Difficult Airway
      • Basic airway management equipment should be immediately available during the provision of neuraxial analgesia
      • Portable equipment for difficult airway management should be readily available in the operative area of labor and delivery units
      • The anesthesiologist should have a preformulated strategy for intubation of the difficult airway
      • When tracheal intubation has failed, ventilation with mask and cricoid pressure, or with a laryngeal mask airway or supraglottic airway device (e.g., Combitube®, Intubating laryngeal mask airway (LMA) [Fastrach™]) should be considered for maintaining an airway and ventilating the lungs
      • If it is not possible to ventilate or awaken the patient, an airway should be created surgically
    • Basic and advanced life-support equipment should be immediately available in the operative area of labor and delivery units
    • If cardiac arrest occurs during labor and delivery, standard resuscitative measures should be initiated
      • Uterine displacement (usually left displacement) should be maintained
      • If maternal circulation is not restored within 4 minutes, cesarean delivery should be performed by the obstetrics team

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

Scientific evidence was derived from aggregated research literature, and opinion-based evidence was obtained from surveys, and other activities (e.g., Internet postings).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1999 (revised 2007 Apr)

GUIDELINE DEVELOPER(S)

American Society of Anesthesiologists - Medical Specialty Society

SOURCE(S) OF FUNDING

American Society of Anesthesiologists

GUIDELINE COMMITTEE

Task Force on Obstetrical Anesthesia

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Task Force Members: Joy L. Hawkins, MD (Chair), Denver, Colorado; James F. Arens, MD, Houston, Texas; Brenda A Bucklin, MD, Denver, Colorado; Richard T. Connis, PhD, Woodinville, Washington; Patricia A. Dailey, MD, Hillsborough, California; David R. Gambling, MBBS, San Diego, California; David G. Nickinovich, PhD, Bellevue, Washington; Linda S. Polley, MD, Ann Arbor, Michigan; Lawrence C. Tsen, MD, Boston, Massachusetts; David J. Wlody, MD, Brooklyn, New York; Kathryn J. Zuspan, MD, Stillwater, Minnesota

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Society of Anesthesiologists. Practice guidelines for obstetrical anesthesia: a report by the American Society of Anesthesiologists Task Force on Obstetrical Anesthesia. Anesthesiology 1999 Feb;90(2):600-11.

GUIDELINE AVAILABILITY

Electronic copies: Available from the Anesthesiology Journal Web site.

Print copies: Available from the American Society of Anesthesiologists, 520 N. Northwest Highway, Park Ridge, IL 60068-2573.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

The following is available:

  • Planning your childbirth: pain relief during labor and delivery.

Available from the American Society of Anesthesiologists Web site.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This summary was completed by ECRI on May 31, 1999. The information was verified by the guideline developer on July 14, 1999. This NGC summary was updated by ECRI Institute on June 26, 2007. The updated information was verified by the guideline developer on July 5, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline that is copyrighted by the American Society of Anesthesiologists.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo